Open AccessMetastatic hormone receptor-positive breast cancer in CDK 4/6 era: An outcome audit
Author(s) -
Rajeev Krishnappa Lakkavalli,
Jitendra Kumar Pehalajani,
Venkatesh Tirumala,
Govind Babu,
D Loknatha,
Linu Abraham Jacob,
Suresh Babu,
A H Rudresha,
Lokesh N Kadabur,
S. Smitha,
G.V. Giri
Publication year - 2021
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_853_18
Subject(s) - metastatic breast cancer , medicine , breast cancer , oncology , hormone receptor , cancer , hormone , retrospective cohort study , metastasis
The treatment landscape of metastatic hormone receptor (HR) positive breast cancer has been changed in recent years. Availability of CDK 4/6 inhibitor and other hormone therapy has changed the treatment algorithm for these patient, we retrospectively analyzed our metastatic HR positive breast cancer patients.